Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdulwhab Shremo Msdi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Annals of Pharmacotherapy|May 28, 2026
Zoliflodacin for Urogenital Gonorrhea InfectionsJoshua T Wollen, Abdulwhab Shremo Msdi, Taryn Eubank
Nutrients|August 14, 2025
Prebiotics Improve Blood Pressure Control by Modulating Gut Microbiome Composition and Function: A Systematic Review and Meta-AnalysisAbdulwhab Shremo Msdi, Elisabeth M Wang, Kevin W Garey
Nutrients|March 13, 2025
Microbiome-Based Therapeutics for Salt-Sensitive Hypertension: A Scoping ReviewAbdulwhab Shremo Msdi, Anahita Haghparast, Kevin W Garey, et al.
Infectious Diseases and Therapy|June 26, 2024
Characterizing Day 1 Area Under the Curve Following Vancomycin Loading Dose Administration in Adult Hospitalized Patients Using Non-Trapezoidal Linear Pharmacokinetic Equations: A Retrospective Observational StudyAbdulwhab Shremo Msdi, Jacinda C Abdul-Mutakabbir, Karen K Tan
Infectious Diseases and Therapy|February 17, 2025
Are All Pharmacokinetic Equations Created Equal? A Comparative Analysis of Trapezoidal and Non-Trapezoidal Methods for Estimating Day 1 Area Under the Curve in Adult Hospitalized Patients with Staphylococcus aureus BacteremiaAbdulwhab Shremo Msdi, Alireza Fakhri Ravari, Jacinda C Abdul-Mutakabbir, et al.
Frontiers in Endocrinology|November 7, 2025
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers impact on the gut microbiome: a systematic reviewElisabeth M Wang, Abdulwhab Shremo Msdi, Vy N Quach, et al.
Clinical Orthopaedics and Related Research|March 19, 2025
Can Oritavancin Be Used for Treatment and/or Suppressive Antimicrobial Therapy of Bone and Joint Infections Caused by Vancomycin-resistant Enterococcus faecium?Martin Krsak, Taylor Morrisette, Laura Damioli, et al.
Frontiers in Pharmacology|July 28, 2022
A Selective Adenylyl Cyclase 1 Inhibitor Relieves Pain Without Causing ToleranceGianna Giacoletti, Tatum Price, Lucas V B Hoelz, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Annals of Pharmacotherapy|May 28, 2026
Zoliflodacin for Urogenital Gonorrhea InfectionsJoshua T Wollen, Abdulwhab Shremo Msdi, Taryn Eubank
Nutrients|August 14, 2025
Prebiotics Improve Blood Pressure Control by Modulating Gut Microbiome Composition and Function: A Systematic Review and Meta-AnalysisAbdulwhab Shremo Msdi, Elisabeth M Wang, Kevin W Garey
Nutrients|March 13, 2025
Microbiome-Based Therapeutics for Salt-Sensitive Hypertension: A Scoping ReviewAbdulwhab Shremo Msdi, Anahita Haghparast, Kevin W Garey, et al.
Infectious Diseases and Therapy|June 26, 2024
Characterizing Day 1 Area Under the Curve Following Vancomycin Loading Dose Administration in Adult Hospitalized Patients Using Non-Trapezoidal Linear Pharmacokinetic Equations: A Retrospective Observational StudyAbdulwhab Shremo Msdi, Jacinda C Abdul-Mutakabbir, Karen K Tan
Infectious Diseases and Therapy|February 17, 2025
Are All Pharmacokinetic Equations Created Equal? A Comparative Analysis of Trapezoidal and Non-Trapezoidal Methods for Estimating Day 1 Area Under the Curve in Adult Hospitalized Patients with Staphylococcus aureus BacteremiaAbdulwhab Shremo Msdi, Alireza Fakhri Ravari, Jacinda C Abdul-Mutakabbir, et al.
Frontiers in Endocrinology|November 7, 2025
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers impact on the gut microbiome: a systematic reviewElisabeth M Wang, Abdulwhab Shremo Msdi, Vy N Quach, et al.
Clinical Orthopaedics and Related Research|March 19, 2025
Can Oritavancin Be Used for Treatment and/or Suppressive Antimicrobial Therapy of Bone and Joint Infections Caused by Vancomycin-resistant Enterococcus faecium?Martin Krsak, Taylor Morrisette, Laura Damioli, et al.
Frontiers in Pharmacology|July 28, 2022
A Selective Adenylyl Cyclase 1 Inhibitor Relieves Pain Without Causing ToleranceGianna Giacoletti, Tatum Price, Lucas V B Hoelz, et al.
Pageof 1